On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .
Lindy discusses the Patented Medicines Pricing Review Board (PMPRB), the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.
She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.
This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.
Contact Information:
www.acceleracanada.com
lindy.forte@acceleracanada.com